Clinical Trial Update: Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update of ABT-751 with carboplatin in advanced lung cancer has been terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• ABT-751 (ABT-751)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Konstantin Dragnev | Conditions: Non Small Cell Lung Cancer, Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-10-12